Microbial Detection System suits drug and vaccine manufacturers.April 30, 2010 -
Milliflex® Quantum rapid microbial detection system enables drug/vaccine manufacturers to respond to microorganism contamination at early stage in production process. Based on membrane filtration and fluorescent staining, compact, nondestructive system is suited for testing raw material, in-process samples, final product, and environmental samples. It consists of reader, camera, and fluorescent reagents used in combination with Milliflex PLUS pump, filtration devices, and media cassettes.
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Original Press release
Millipore Corp.
80 Asby Rd.
Bedford, MA, 01730
USA
Millipore Launches Milliflex Quantum Rapid Detection System for Microbial Contamination Testing
Based on proven technologies, provides results faster than traditional testing
Billerica, Massachusetts - Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced the launch of its new Milliflex® Quantum rapid microbial detection system. The system enables drug and vaccine manufacturers to respond to microorganism contamination earlier in the production process.
"The Milliflex Quantum system provides results faster than traditional testing methods. It is designed to significantly improve product quality management, helping customers to release product to the market sooner and avoid line shutdowns," said Roland Heinrich, Ph.D., Vice President for Process Monitoring in Millipore's Bioprocess Division.
"The system is based on two widely adopted technologies - membrane filtration, performed with proven Milliflex membrane filtration devices, and fluorescent staining - to ensure consistent, reliable results," Heinrich continued. "In addition, the validation process is streamlined because it involves only minimal changes to the compendial tests currently used."
The Milliflex Quantum system is ideal for testing raw material, in-process samples, final product and environmental samples. It is non-destructive, an important feature that enables operators to grow microorganisms in order to identify them with standard ID technology. The majority of rapid test systems are destructive in nature, which means they offer limited capabilities for microorganism investigation and identification.
The Milliflex Quantum system consists of a reader, camera and fluorescent reagents used in combination with the Milliflex PLUS pump, Milliflex filtration devices and media cassettes. It is compact and easy to learn, for smooth integration into an existing laboratory set-up. Millipore offers a comprehensive range of services to support the system's implementation, including installation, operational and performance qualification guidelines.
"This innovative new system extends Millipore's rapid microbial detection portfolio, which includes the recently launched MilliPROBE® detection system for mycoplasma," Heinrich noted. "The simple two- to three-step method ensures accurate microbiological results, while reducing overall time to result."
About Millipore
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,100 employees worldwide. For more information, please contact Millipore Tech Service at 1-800-548-7853 or 951-676-8080 or visit www.millipore.com.
ADVANCING LIFE SCIENCE TOGETHER®
Research. Development. Production.
|
|
|
|
|
|
|
| 
